Antiglycosphingolipid immune responses in neurology - The Vienna experience with isotypes, subclasses, and disease

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 353-362

  Gatterbauer, B ^a   Neisser, A ^b   Bernheimer, H ^a   Schwerer, B ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GANGLIOSIDE GM1; GLYCOSPHINGOLIPID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE;

ADRENOLEUKODYSTROPHY; AUTOIMMUNE DISEASE; CAMPYLOBACTER JEJUNI; CONFERENCE PAPER; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MOTOR NEUROPATHY; NEUROLOGIC DISEASE; NEUROLOGY; PARAPROTEINEMIA; SENSORIMOTOR NEUROPATHY; SUBCLAVIAN STEAL SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACRONICTA LEPORINA; CAMPYLOBACTER JEJUNI; MARTES PENNANTI;

EID: 0031928965     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09687.x     Document Type: Article

References (30)

1. MARCUS, D. M., N. LATOV, B. P. HSI & G. K. GILLARD. 1989. Measurement and significance of antibodies against GM1 ganglioside. J. Neuroimmunol. 25: 255-259.
2. SAITO, M., N. KASAI & R. K. YU. 1985. In situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal. Biochem. 148: 54-58.
3. WILLISON, H. J. & P. G. E. KENNEDY. 1993. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J. Neuroimmunol. 46: 105-112.
4. SEISER, A., G. POTZL, G. SAFOSCHNIK, S. PICHLER, H. BERNHEIMER & B. SCHWERER. 1994. GM1 antibodies in Guillain-Barré syndrome: Isotypes, course and clinical outcome. Wien. Klin. Wochenschr. 106: 159-163.
5. PESTRONK, A. 1991. Invited review: Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle & Nerve 14: 927-936.
6. FINSTERER, J., B. SCHWERER, R. E. BITTNER & B. MAMOLI. Liquorpheresis and immunoglobulins in Lewis-Sumner syndrome presenting as brachial plexopathy. Manuscript submitted.
7. SCHWERER, B., S. PICHLER, H. BERNHEIMER, G. SAFOSCHNIK & G. PÖTZL. 1994. Chronic progressive motor polyneuropathy after ganglioside treatment. J. Neurol. Neurosurg. Psychiatry 57: 238-241.
8. GARCIA GUIJO, C., A. GARCIA-MERINO & G. RUBIO. 1995. Presence and isotype of antiganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system. J. Neuroimmunol. 56: 27-33.
9. QUARLES, R. H., A. A. ILYAS & H. J. WILLISON. 1986. Antibodies to glycolipids in demyelinating disease of the human peripheral nervous system. Chem. Phys. Lipids 42: 235-248.
10. SADQI, S. A., F. P. THOMAS, K. KILIDIREAS, S. PROTOPSALTIS, A. P. HAYS, K. W. LEE, S. N. ROMAS, N. KUMAR, L. VAN DEN BERG, M. SANTORO, D. J. LANGE, D. S. YOUNGER, R. E. LOVELACE, W. TROJABORG, W. H. SHERMAN, J. R. MILLER, J. MINUK, M. A. FEHR, R. I. ROELOFS, D. HOLLANDER, F. T. NICHOLS, H. MITSUMOTO, J. J. KELLEY, T. R. SWIFT, T. L. MUNSAT & N. LATOV. 1990. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 40: 1007-1072.
11. NEISSER, A., B. SCHWERER, M. GRAF & H. BERNHEIMER. A new binding pattern of serum IgM kappa antibodies against gangliosides in sensorimotor neuropathy. Manuscript submitted.
12. CHIBA, A., S. KUSUNOKI, H. OBATA, R. MACHINAMI & I. KANAZAWA. 1993. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies. Neurology 43: 1911-1917.
13. WILLISON, H. J., A. ALMEMAR, J. VEITCH & D. THRUSH. 1994. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology 44: 2395-2397.
14. SCHWERER, B. & A. NEISSER. 1997. Immunglobulin-Subklassenmuster von Antikörpern gegen Gangliosid GQ1b bei Patienten mit Miller-Fisher-Syndrom. Neuropsych. 11: 47.
15. NEISSER, A., H. BERNHEIMER, T. BERGER, A. P. MORAN & B. SCHWERER. 1997. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect. Immun. 65: 4038-4042..
16. ASPINALL, G. O., A. G. MCDONALD, T. S. RAJU, H. PANG, A. P. MORAN & J. L. PENNER. 1993. Chemical structures of the core regions of Campylobacter jejuni semtypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213: 1017-1027.
17. ASPINALL, G. O., A. G. MCDONALD, T. S. RAJU, H. PANG, L. A. KURJANCZYK, J. L. PENNER & A. P. MORAN. 1993. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur. J. Biochem. 213: 1029-1037.
18. ASPINALL, G. O., A. G. MCDONALD, H. PANG, L. A. KURJANCZYK & J. L. PENNER. 1994. Lipopolysaccharides of Campylobacter jejuni serotype O:19: Structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33: 241-249.
19. SCHWERER, B., A. NEISSER, R. J. POLT, H. BERNHEIMER & A. P. MORAN. 1995. Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. J. Endotox. Res. 2: 395-403.
20. ENDO, T., D. D. SCOTT, S. S. STEWART, S. K. KUNDU & D. M. MARCUS. 1984. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. Adv. Exp. Med. Biol. 174: 455-461.
21. HIRANO, T., H. MIYAHIMA, O. TANIGUCHI, A. UEDA, S. TARAI, H. HASHIMOTO, S. HIROSE & K. OKUMURA. 1988. Anti asialo GM1 antibody detected in the patients' sera from systemic lupus erythematosus and Behcet's diseases with neurological manifestations. Jpn. J. Med. 27: 167-171.
22. COSTALLAT, L. T., R. M. DE OLIVEIRA, M. B. SANTIAGO, W. COSSERMELLI & A. M. SAMARA. 1990. Neuropsychiatriv manifestations of systemic lupus erythematosus: The value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. Clin. Rheumatol. 9: 489-497.
23. MARTINEZ, X., M. TINTORÉ, J. MONTALBAN, J. ORDI, M. VILARDELL & A. CODINA. 1992. Antibodies against gangliosides in patients with SLE and neurological manifestations. Lupus 1: 299-302.
24. MOSER, H. W., K. O. SMITH & A. B. MOSER. 1995. X-Linked adrenoleukodystrophy. In The Metabolic and Molecular Bases of Inherited Disease, C. R Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds.: 2325-2349. McGraw-Hill. New York.
25. AUBOURO, P. 1996. X-linked adrenoleukodystropy. In Handbook of Clinical Neurology, Vol. 22/66, H. W. Moser, Ed.: 447-483. Elsevier. Amsterdam.
26. POWERS, J. M., Y. LIU, A. M. MOSER & H. W. MOSER. 1992. The inflammatory myelinopathy of adrenoleukodystrophy: Cells, effector molecules, and pathogenic implications. J. Neuropathol. Exp. Neurol. 51: 630-643.
27. GRIFFIN, D. E., H. W. MOSER, Q. MENDOZA, T. R. MOENCH, S. O'TOOLE & A. B. MOSER. 1985. Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy. Ann. Neurol. 18: 660-664.
28. BERNHEIMER, H., H. BUDKA & A. P. MÜLLER. 1983. Brain tissue immunoglobulins in adrenoleukodystrophy: A comparison with multiple sclerosis and systemic lupus erythematosus. Acta Neuropathol. (Berlin) 59: 95-102.
29. BUDKA, H., H. BERNHEIMER, J. J. HAAIJMAN & J. RADL. 1985. Occurrence of IgA subclasses (IgA1 and IgA2) in the human nervous system. Correlation with disease. Int. Arch. Allergy Appl. Immunol. 76: 107-115.
30. BERNHEIMER, H., P. MAZAL & B. SCHWERER. 1993. Immune reactions in adrenoleukodystrophy and multiple sclerosis. Trans. Am. Soc. Neurochem. 24: 230.